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Abstract
Aim of this study was to estimate the cost that is borne by the Italian National Health Service, families, and social
security due to very low birth weight infants (VLBWIs) without prematurity-related morbidities up to the age of
18 months. We followed up on 150 VLBWIs and 145 comparable full-term infants (FTIs) who were born in one of 25
different neonatal intensive care units upon discharge from the hospital and at six and 18 months of age. The
average length of the primary hospitalisation of the VLBWIs was 59.7 days (SD 21.6 days), with a total cost of
€20,502 (SD €8409), compared with three days (SD 0.4 days) with a total cost of €907 (SD €304) for the FTIs. The
total societal cost of the VLBWIs for the first 18 months of life was €58,098 (SD €21,625), while the corresponding
figure for FTIs was €24,209 (SD €15,557). Among VLBWIs, both low birth weight and gestational age were correlated
with the length of hospitalisation after birth (r2 = 0.61 and r2 = 0.57, respectively; p values < 0.0005). Our findings
highlight that the existing DRGs and tariffs inadequately reflect the actual costs for Italian National Health Service.
Background
Approximately 552,000 infants are born in Italy each year,
and 1 % of them are very low birth weight infants
(VLBWIs) [1], with a birth weight under 1500 g (401 ≤ birth
weight ≤1500) or a gestational age (GA) under 30 weeks
(22 ≤GAweeks ≤30). With increasing earlier use of ante-
natal corticosteroids [2], assisted ventilation, and surfactant
[3] and with changing attitudes [4] towards intensive care,
survival rates for very preterm births, especially those in-
fants born before 28 weeks of gestation, improved strikingly
by the mid 1990s [5–7]. However, preterm birth is still as-
sociated with an increased risk of developing a broad range
of short-term and long-term complications compared to
full-term birth [8, 9]. A substantial body of literature has re-
ported that very low birth weight infants are at an increased
risk of negative outcomes, including motor and sensory im-
pairment [10], learning difficulties [11–14] and behavioural
problems [15–18]. The care of VLBWIs demands extensive
resources, including considerable hospital costs at birth, as
previous studies have demonstrated [19–22], and the use of
hospital resources remains higher for VLBWIs in early
childhood compared to their full-term peers [19, 23–26].
The economic consequences of very preterm birth to soci-
ety need to be further investigated. Only a few studies have
explored the health care and non-health care costs of very
preterm children after the first year of life and compared
these costs with the costs associated with children of
normal birth weight [19]. Although there is evidence
that hospital costs represent a considerable portion of
the total cost, families also suffer direct economic
losses, such as those losses resulting from paying un-
covered drugs, travelling costs, or reduced earnings.
These costs are rarely investigated.
The aim of this study was to assess the societal cost
of the care for the VLBW population born in Italy up
to the age of 18 months after correcting for prematur-
ity and to compare these costs to the costs of healthy
normal birth weight infants. To reach this aim we used
a sample of 150 VLBWIs without premature-related
morbidities.
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This study is part of a multicentre, incidence-based, longi-
tudinal study labelled Neonatal Adequate Care for Quality
of Life (NEO-ACQUA). This is the first Italian study to lon-
gitudinally follow a cohort of 178 VLBWIs matched to 178
healthy, full term infants (FTIs) from birth to evaluate their
clinical outcomes, the quality of life for their parents, and
the cost involved in their care. The study protocol and the
first results were previously published [27].
The VLBWIs were enrolled in neonatal intensive care
units (NICUs) of 25 Italian hospitals from January 1,
2006 to December 31, 2006. Only level III NICUs were
included in the study [27]. The infants were recruited
consecutively, and the inclusion criteria were as follows:
gestational age ≤ 30 weeks and/or birth weight ≤ 1500 g;
no documented neurological pathology, as shown by
negative cerebral ultrasound (periventricular leukomala-
cia up to stage 1); intraventricular haemorrhage up to
stage 1 or 2; no sensory deficit (retinopathy up to stage
1 or 2); neonatal hearing screening through auditory
brainstem response or otoemissions within the norm at
the 34th week; and no malformation syndromes and/or
major malformations.
For each VLBWI, a gender-matched full-term infant
with a gestational age between 37 and 42 weeks and a 5-
min Apgar score ≥ 8 was enrolled at the same hospital.
In addition, the full-term infant’s mother was the same
age (+/− 5 years) and the parents belonged to the same
Hollingshead social class as those parents of the VLBWI
[28]. This social classification uses both parents occupa-
tional group for a scale from 0 (occupations that do not
require an academic foundation) to 90 (occupations that
require highly specialised education and training). The
gestational age was determined by an ultrasound examin-
ation for VLBWIs and was calculated from the last men-
strual period for controls. For both VLBWIs and controls,
the maternal inclusion criteria were: Italian nationality,
maternal age over 18 years, no manifest psychiatric and
cognitive pathology and no evidence of drug addiction.
This study was approved by the ethics committees of the
participating hospitals, and written consent to participate
in the study was obtained from all infants’ parents.
The use of resources was documented through ad hoc
questionnaires administered to clinicians and parents.
The questionnaires were tested in a pilot study with 10
clinicians and parents. Because this study was conducted
from the societal perspective, we collected and classified
resource consumption as follows: (i) in-hospital health-
care costs, (ii) other healthcare costs borne by the Italian
National Health Service (SSN), (iii) health care and non-
healthcare costs directly paid by the families of the in-
fants, and (iv) working days lost by parents due to their
infant’s birth.
Study instruments and identification of costs
The background data from the perinatal period were
collected by clinicians using each infant’s medical re-
cords. Use of resources was collected through 3 inter-
views to parents conducted at the end of each relevant
period: from birth to discharge from hospital (T0), from
birth to the corrected age of six month (T6), and from
corrected age of six months to the corrected age of
18 months (T18).
To calculate the cost of each admission to the hospital
upon birth, we prospectively collected data on the use of
drugs, laboratory and imaging tests; days of parenteral
nutrition; and transfusions for each infant. For each
VLBWI, we consolidated these costs according to prices
(drugs) and national tariffs (tests, parenteral nutrition,
and transfusions). To these costs, we added the cost of
the hospital stay on the basis of a per diem value. The
average cost per NICU day was calculated as the total
cost for personnel, medical devices and equipment for
the entire NICU divided by the total number of NICU
days delivered in 2008. Finally, to include overheads, we
added to these figures a fixed percentage of direct cost
estimated with the help of the hospital administrative
departments. The cost of the initial hospitalisation for
the control infants were based on the existing fee reim-
bursed by the regional authority to hospitals for a
healthy newborn infant, which was assumed to be a
proxy for the actual cost.
Information from the parents concerning their travel
distance to the birth hospital, frequency of visits and
working hours lost during the initial hospitalisation was
collected for both groups.
At six and 18 months, the following data were col-
lected from the parents: infant’s re-hospitalisations, out-
patient visits, diagnostic tests (laboratory and imaging
tests), drugs, rehabilitation therapies, psychological sup-
port, paid care and informal care. The parents also re-
ported any out-of-pocket payments for each of these
items. The monetary value attributed to the outpatient
care (visits, tests, rehabilitation, drugs) provided by the
SSN was calculated using the standard tariffs used to
pay providers.
Travel costs were calculated based on the information
collected from the parents about their travelling dis-
tances and frequency of visits. The amount spent was
calculated on the basis of the available average cost per
km by car [29] and by train [30] in Italy.
The parents were also requested to detail working days
lost during the period after the infant’s birth and to indicate
if they had abandoned their job. Their wages were used to
evaluate their loss of production on the assumption that
their earnings reflect their productivity. The estimated
losses were based on the average daily wages for each par-
ent’s occupational group [31]. In Italy, social security
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support maternity for a period of five months (two months
before birth and three months after). After this period, par-
ental leave is available for either of the parents until the
child reaches an age of three years (a maximum of six
months leave can be taken during the three years). During
childcare leave, the parent who stays home is paid financial
support depending on their income level. We separated
productive loss figures based on whether the parents were
compensated by social insurance.
Statistical analyses
The costs are presented as the means and standard devi-
ations from the means. Analysis of variance was used to
detect cost differences between the groups. P < 0.5 was
considered significant. 95 % CI was also calculated for
socio-demographic variables.
We performed χ2 tests on dichotomised variables; ana-
lyses of variance were used to compare means (costs).
All costs are expressed in 2008 Euros and the discount
rate was 3 % per year. The analyses were performed with
Stata 9 (Stata Corp., College Station, TX).
Results
For 150 eligible VLBWIs and 145 eligible FTIs, data
were collected for the entire study period. The demo-
graphic characteristics of both groups are shown in
Table 1. They were very similar in terms of gender and
the mother’s education in years. They differed slightly in
terms of the father’s education years (12.5 years in the
VLBWI group vs. 11.5 years in the control group) and
Hollingshead social class score (51.6 vs. 54.8). As ex-
pected, the two groups differed greatly in birth weight
(1132 vs. 3297 g; p < 0.0005) and gestational age at birth
(29.1 vs. 38.3 weeks; p < 0.0005).
Birth hospitalisation period
For the VLBWIs, the average length of the initial hospi-
talisation was 59.7 days (SD 21.6 days), while for the
FTIs, it was 3.0 days (SD 0.4 days). The mean cost of the
hospitalisation for the VLBWIs was €20,502 (SD €8409).
The average cost of hospital staff accounted for 73.9 %
of the total cost. Drugs and diagnostic procedures
accounted for only 4.1 % and 2.1 %, respectively, of the
total cost. The mean total societal cost per infant during
the hospitalisation period was €32,460, with the hospital
cost accounting for 63.2 % of the total. Travel expenses
and productivity losses accounted for 7.2 % and 29.6 %
of the total societal cost, respectively. In the control
group, the mean total societal cost per infant was €2640;
for these patients, the hospitalisation, travel and prod-
uctivity losses accounted for 34.3 %, 1.6 % and 63.1 % of
the cost, respectively (Table 2). The hospital cost and
travelling cost were 23 and 57 times higher, respectively,
for VLBWIs compared with the control group. The
productivity losses due to the delivery hospitalisation
(€9606) were much larger for the VLBWIs than for the
control group (€1692) due to the much longer hospital
stay of the infant.
From discharge to six months (T0-T6)
A total of 48 VLBWIs (32 %) and 15 FTIs (10.3 %) were
re-hospitalised during the first six months after discharge
(Table 3). The mean number of re-hospitalisations per
VLBWI during the period was 0.4, and the mean length of
stay was 4.0 days. Overall, the mean cost of VLBWIs to
the Italian SSN in the first six months after discharge was
Table 1 Sample characteristics (clinical and socio-demographic
variables)
Mean Mean p value
(SD) (SD)
95 % CI 95 % CI
Total enrolled infants VLBW FTI χ2 = 0.0275; n.s.
Gender n = 150 n = 145
Female (%) 52.0 51.0
Male (%) 48.0 48.9
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n = 123 n = 116
51.6 54.8 t = −0.48; n.s.
(19.9) (20.5)
48.1−55.1 51.1−58.5
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€1433, with re-hospitalisation and drugs accounting for
56.0 % and 19.6 %, respectively, of the total cost. The cost
of care borne by the Italian SSN for FTIs was €565, with
re-hospitalisation accounting for 71.1 % of the total cost.
All costs borne by the Italian SSN were significantly higher
in the VLBWI group compared with the control group.
There was no difference between the two groups concern-
ing paediatrician visits, other specialist visits, laboratory
tests, imaging, and rehabilitation services paid by the
families. However, the pharmaceutical care paid by fam-
ilies was significantly higher in the VLBWIs (€269 vs. €69,
p < 0.0005). The paid and informal care and the productiv-
ity losses were not significantly different between the two
groups. However, the families of VLBWIs had higher costs
for travelling (€96 vs. €56; p = 0.0001). The overall mean
societal cost for the first six months after discharge was
€13,382 for the VLBWIs and €12,368 for the FTIs, with
the difference mainly due to hospital and drug costs borne
by the Italian SSN.
From six months to 18 months (T6-T18)
During the one-year period from six to 18 months after
the initial hospitalisation, the cost borne by the Italian
SSN for VLBWIs remained remarkably higher than the
cost of the controls (€820 vs. €391; p = 0.0002) (Table 4).
With the exception of general paediatric services, all cat-
egories of medical costs were higher for the VLBWIs
compared to the FTIs. However, the cost of this period
was substantially lower than that in the six months follow-
ing the first hospitalisation. On average, the VLBWIs had
a daily SSN medical cost of €12.4 in the first six months
after discharge and €3.2 in the following 12 months.
In this period, only paid and unpaid care and product-
ivity losses were relevant costs borne by the families. Al-
though the differences were not significant, productivity
losses tended to be higher for the families of the
VLBWIs compared to the families of the FTIs (€6323 vs.
€4373, n.s.), while the societal cost due to informal care
was similar between the groups (€4790 vs. €4334, n.s).
The total societal costs over this 12-month period were
€12,257 for the VLBWIs and €9202 for the control
group (n.s.), with the difference mainly due to productiv-
ity losses and paid care.
Overall costs
The mean total cost per VLBWI from birth to the 18th
month after discharge was €58,098, while the corre-
sponding cost per FTI was €24,209. The medical costs
declined over time for both groups. During the observa-
tion period, 62.6 % of the medical costs occurred in the
most costly patients’ quartile and only 4.6 % occurred in
the least expensive quartile (Fig. 1). Among VLBWIs, the
correlation between birth hospitalisation cost and birth
weight was significant (r2 = −0.20; p < 0.0005). The follow-
ing correlations were also significant: birth hospitalisation
cost and gestational age (r2 = −0.24; p < 0.0005), Length of
Stay (LOS) and birth weight (r2 = −0.61; p < 0.0005), and
LOS and gestational age (r2 = −0.57; p < 0.0005).
The non-medical costs had a different pattern. For the
VLBWIs, the non-medical costs were higher during the
delivery hospitalisation because of the longer stay. The
productivity losses tended to be similar between the two
groups in the six months after discharge because the ma-
ternity leave for the mothers of the VLBWIs was aug-
mented by the period spent in the hospital. In the third
period of observation (from six to 18 months after dis-
charge), the prodcpeuctivity losses and paid care were
higher for the families with VLBWIs, thus making non-
medical costs significantly higher (€11,437 vs. €8881 for
families of FTIs; p < 0.0005). The productivity losses were
mainly borne by social security during the hospitalisation
and the first six months after discharge (Fig. 2). Particu-
larly, in the second period of observation (six months after
discharge), the proportion of the productivity cost borne
by social security was similar (approximately 65 %). How-
ever, in the third period (from six months to 18 months
after discharge), the families with the FTIs suffered signifi-
cantly higher direct productivity losses because they did
not benefit from extra parental leave due to the condition
of the infant. Overall, the total productivity losses for the
entire observation period amounted to €19,203 and €8337
for VLBWI and FTI families, respectively.
Table 2 Costs from birth to discharge (€)







Very low birth weight
infants (LOS 59.7; SD 21.6)
150 100 20,502 (8409) t = 28.66
p< 0.0005
Full-term infants
(LOS 3.0; SD 0.4)
145 100 907 (324)
Travelling 278 100
Very low birth weight
infants
140 100 2352 (3143) t = 8.8
p< 0.0005
Full-term infants 138 100 41 (63)
Productivity losses 295 100
Very low birth weight
infants
150 100 9606 (4396) t = 21.88
p< 0.0005
Full-term infants 145 100 1692 (1048)
Total societal cost of
initial hospitalisation
(from birth to discharge)
295 100
Very low birth weight
infants
150 100 32,460 (9136) t = 35.56
p< 0.0005
Full-term infants 145 100 2640 (826)
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Table 3 Total cost (€) during the first six months after discharge for the families of VLBWIs and FTIs (T0-T6)
Costs funded by the
Public Health System
VLBWIs VLBWIs VLBWIs FTIs FTIs FTIs p value
n =150 n = 150 n = 150 n = 145 n = 145 n = 145 (costs)
Resource users % Resource consumption Mean Mean cost (SD) Resource users % Resource consumption Mean Mean cost (SD)




98.6 4.9 71 (52) 98.6 4.5 64 (35) t = 1.24
n.s
Specialist Visits (Follow-up as an
outpatient at the birth hospital)
99.3 4.3 90 (59) 57.2 0.9 19 (22) t = 13.61
p < 0.0005
Other specialist visits 72.6 2.5 53 (57) 18.6 0.2 4 (10) t = 10.06
p < 0.0005
Drugs 76.0 281 (211) 63.4 70 (79) t = 4.11
p = 0.0001
Laboratory tests 55.3 3.2 14 (23) 12.4 0.4 2 (9) t = 6.21
p < 0.0005
Imaging tests 73.3 2.2 106 (114) 10.3 0.1 5 (20) t = 10.39
p < 0.0005
Rehabilitation therapy 20.0 0.9 10 (23) 0.7 0.0 0.0 (0.0) t = 4.09
p < 0.0005
Psychological support 7.6 0.3 5 (24) 0.0 0.0 0.0 t = 2.53
p = 0.01
Total cost funded by the
Public Health System
1433 (1256) 565 (130) t = 3.71
p = 0.0002
Costs funded by Families
Drugs 17.0 269 (648) 22.1 69 (42) t = 4.89
p < 0.0005
Paediatric visits 30.6 1.0 57 (124) 20.7 0.5 54 (41) t = 0.20
n.s
Other specialists visits 6.0 0.1 5 (27) 4.8 0.1 4 (27) t = 0.22
n.s
Laboratory and imaging tests 2.6 0.0 1 (12) 3.4 0.0 2 (10) t = −0.47
n.s












Table 3 Total cost (€) during the first six months after discharge for the families of VLBWIs and FTIs (T0-T6) (Continued)
Paid informal care 33.3 163 (873) 34.7 221 (1192) t = −0.48
n.s
Unpaid informal care 28.0 1110 (2431) 28.0 1016 (2196) t = 0.35
n.s
Travelling 89.3 65.6 (travels) 96 (111) 87.6 2.8 (travels) 56 (43) t = 3.97
p = 0.0001
Productivity losses 66.9 10,246 (6073) 63.8 10,380 (5960) t = −0.19
n.s
Total cost funded by
families and productivity losses
11,948 (3563) 11,802 (3623) t = 0.26
n.s













Table 4 Total cost (€) from six months to 18 months after discharge for the families of VLBWIs and FTIs (T6-T18)
Costs funded by the Public
Health System
VLBWIs VLBWIs VLBWIs FTIs FTIs FTIs p value
n = 150 n = 150 n = 150 n = 145 n = 145 n = 145 (costs)
Resource users % Resource consumption mean Mean cost (SD) Resource users % Resource consumption mean Mean cost (SD)




98.0 5.4 78 (70) 97.2 5.7 81 (75) t = −0.35
n.s
Specialist visits (Follow-up as an
outpatient at the birth hospital)
96.6 3.5 74 (49) 53.1 0.9 20 (23) t = 12.06
p < 0.0005
Other specialist visits 54.0 1.6 33 (50) 15.8 0.2 4 (13) t = 6.66
p < 0.0005
Drugs 83.3 104 (84) 86.2 10 (54.0) t = 5.66
p < 0.0005
Laboratory tests 29.3 2.3 10 (22) 19.3 0.6 3 (10) t = 3.23
p < 0.001
Diagnostic tests 28.0 0.6 33 (77) 8.9 0.1 4 (15) t = 4.44
p < 0.0005
Rehabilitation therapy 12.6 1.2 13 (52) 1.4 0.3 4 (39) t = 1.76
n.s
Psychological support 5.3 0.5 9 (89) 0.0 0.0 0.0 t = 1.25
n.s
Total cost funded by the public
health System
820 (145) 391 (87) t = 6.20
p < 0.0005
Costs funded by families
Drugs 13.5 109 (956) 15.3 11 (23) t = 1.34
n.s
Paediatric visits 30.6 1.1 131 (268) 20.7 0.6 68 (170) t = 2.43
p = 2.43
Other specialists visits 6.0 0.1 4 (20) 6.2 0.1 9 (44) t = −1.21
n.s
Laboratory and diagnostic tests 2.0 0.1 1 (5) 1.4 0.0 0 (0) t = 0.16
n.s












Table 4 Total cost (€) from six months to 18 months after discharge for the families of VLBWIs and FTIs (T6-T18) (Continued)
Paid informal care 43.4 1183 (355) 44.2 564 (257) t = 1.71
n.s
Unpaid informal care 40.0 3617 (612) 37.0 3770 (615) t = 0.35
n.s
Travelling 70.0 3.0 69 (85) 51.0 1.2 16 (23) t = 7.23;
p < 0.000
Productivity losses 20.2 6323 (9848) 11.1 4373 (1135) t = −0.19
n.s
Total cost funded by families and
productivity losses
11,437 (2583) 8811 (2007) t = 1.85
(p = 0.06)













Of the 106 mothers of VLBWIs whose employment
status was available at the end of the observation period,
22 had lost their jobs (20.8 %). The corresponding figure
for the 99 mothers of FTIs was 15 (15.2 %). In total,
4.6 % and 0.9 % of mothers of VLBWIs and FTIs, re-
spectively, remained on maternity leave without income.
Discussion
Our study population included 150 “healthy” VLBWIs
born at one of 25 hospitals located in eight different Ital-
ian regions and admitted to the internal NICU. In this
study, we compared this cohort of infants with a
matched cohort of FTIs to report additional medical and
societal costs attributable to very low birth weight and
early gestational age. As best we know, this is the first
study investigating the cost of premature babies in Italy
that was based on primary data and is one of the very
few studies on the cost of premature babies performed
in non-Anglo-Saxon countries. Most studies on the cost
of preterm babies have focused on the neonatal intensive
care costs and hospital costs during the birth hospitalisa-
tion [32]. In contrast, our study included all of the costs
related to the infant’s care during the first 18 months
after birth discharge and documented paid and informal
care and productivity losses. We collected data related
to each hospitalisation, enabling us to attribute a monet-
ary value to all the medical resources used to estimate
the actual cost of each VLBWI’s hospital stay. The cost
borne by the Italian Ssn was primarily calculated on the
basis of information from the medical charts by physi-
cians and other information collected from the adminis-
trative offices in each hospital. The cost borne by
families were estimated based on questionnaires admin-
istered to the parents at three different points in time.
For the birth hospitalisation of VLBWIs, we could not
use DRGs because they do not reflect actual costs, which
our study confirms [33]. Using actual national tariffs,
our estimates for the mean cost for the birth admission
would have been €4833, with a range between €1987
and €17,162; instead, according to our estimates, the
mean cost was €20,502, with a range between €7852 and
€47,162.
Previous studies have shown that the cost of the initial
hospitalisation in very preterm infants is high [22, 34, 35]
and that the cost increases with decreasing gestational age
and birth weight and with increasing length of hospital
stay. Our results fully confirm these findings. Our data
suggest that among VLBWIs, both low birth weight and
gestational age are correlated with the length of stay of the
index hospitalisation (r2 = 0.61 and r2 = 0.57, respectively;
p < 0.0005) and that when birth weight and gestational age
are used in the same model, they explain 73 % of variabil-
ity in the length of stay. This finding suggests that these
Fig. 2 Healthcare cost distribution during the observation period
Fig. 1 Productivity losses (€) from birth up to 18 months after the infant’s discharge
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variables may be used to design tariff systems that better
correlate costs than the present, limited numbers of DRGs
available for premature babies.
In comparison to previous studies from the US, the
UK, Sweden, and Finland, our costs (in 2008 currency)
for the initial hospital stay were lower; costs for VLBWIs
in other studies have been between €38,660 (2008 cur-
rency) and €116,180 (2006 currency). However, our
study focused on VLBWIs without prematurity-related
morbidities, which can cause significant additional costs.
Prematurity-related complications, such as infections
and pulmonary problems, may prolong the initial hospi-
talisation, resulting in additional costs [36]. Our results
support the conclusions of Koveranska et al. [37], who
made a distinction between preterm infants with and
without prematurity-related morbidities. Infants who
were born very preterm without prematurity-related
morbidities, as in our study population, did not cause
significant additional costs for the healthcare service
after the initial hospitalisation compared with infants
who were born healthy at term. In contrast, individuals
with prematurity-related morbidities not only consume
more health care resources but also have higher long-
term costs [37].
In previous studies, the mean LOS for very preterm in-
fants varied from 41 to 64 days [20–22, 24, 38–40]. Most
of these studies report a median LOS shorter than the
mean LOS, indicating the presence of a small number of
outliers who use a large amount of resources [20–22]. In
agreement with such evidence, our study found a mean
LOS of 59.7 days and a median LOS of 47 days.
The total cost of premature individuals decreases over
time, and the initial hospitalisation composes the largest
cost burden [23, 24, 26, 37, 40]. In agreement with these
studies, in our study, the cost of the birth hospitalisation
for VLBWIs accounted for 89 % of the total healthcare
cost and 60 % of the total societal cost over the observa-
tion period. After the initial hospitalisation, the health-
care cost remained higher for VLBWIs compared to
FTIs, primarily due to re-hospitalisations and pharma-
ceutical therapies. These costs declined over time and
tended to converge in the last observation period (from
six to 18 months after discharge). It is important to
highlight that the absolute values of these costs are mod-
est (€820 and €391 for VLBWIs and FTIs, respectively)
and thus cannot radically modify the cost-effectiveness
profile of interventions during the first hospitalisation
and following periods. This finding confirms the crucial
role of neonatal care received during birth hospitalisa-
tion and suggests that attempts to improve quality and
cost-effectiveness of interventions for these infants
should be focused during this phase [32].
In our study, the paid care and informal care costs
were similar between the two groups in the first six
months after discharge, primarily because mothers (and
less fathers) benefited from parental leaves and thus
could directly take care of the infant. However, in the
following year, the additional cost of paid care for the
families with VLBWIs was more than two-fold higher
than the cost for the parents of FTIs, which created an
additional economic burden that was even higher than
the additional cost for healthcare. In contrast, in this
period, the unpaid infant care was the same between the
preterm and the control group. This divergent pattern
suggests that paid care is additional and not substitutive
to informal care.
The families of VLBWIs suffered from higher product-
ivity losses because they had fewer working days, and
the mothers were also more likely to lose their jobs.
These findings are consistent with studies from other
European countries, which were recently summarised in
a review of the existing literature by Hodek et al. [41],
who illustrated the significant burden of prematurity on
parents.
To appreciate the societal implications of paid and in-
formal care and productivity losses, it is important to
separate private costs from social security costs. In the
first periods (during the initial hospitalisation and the
first months after the delivery), all parents receive social
security support in the form of parental leave. After-
wards, the mothers of VLBWIs seem to benefit from
additional support provided by social security in the
form of prolonged parental leaves (although with income
reduction). For the families of FTIs, such benefits are
much more limited; the mothers are more frequently
back at work, but they also often have to reduce their
working hours and miss working days to care for their
infants. This fact may explain why in this period
mothers of these infants suffer higher economic losses
than the mothers of VLBWIs.
This evidence must be interpreted in the specific context
of the Italian society, where female participation to the
labour market is low compared with the rest of Europe.
Infant care is provided by the parents (mainly mothers)
and unpaid caregivers, while the cost borne for paid care
is limited. Interestingly, there is no difference between the
two groups in the fraction of infants receiving unpaid care
and the average time spent per infant, thus suggesting that
in Italy, informal, unpaid care provided by relatives is cru-
cial for preterm infants.
The major strength of our study is the use of a na-
tional cohort of VLBWIs as a study population. The use
of this population avoids the selection bias that charac-
terises studies that are based in smaller geographic re-
gions or a single hospital. We used data on true hospital
admissions. Moreover, we took into account the family
perspective when calculating the overall cost of preterm
births, and we quantified the main categories that should
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be evaluated to adequately measure the burden of pre-
term birth on families. However, many of the adverse
consequences of preterm birth, such as cognitive and be-
havioural problems, are likely to be diagnosed later; con-
sequently, the effect of these conditions on later costs
should be studied at an older age. Thus, a limitation of
this study is that the data on the resources used were
limited to 18 months of age.
Conclusions
The present study showed that for VLBWIs born in
Italy, the initial hospitalisation accounted for the clear
majority of the healthcare cost during the first 18 months
of life. However, a minority of children born very pre-
term had a long initial LOS and more re-admissions and
outpatient visits during the follow-up period, resulting in
higher healthcare costs for this group. A reduced hos-
pital length of stay, a higher gestational age and an in-
creasing birth weight are likely to result in cost savings
and thus improve the cost-effectiveness of care. The fur-
ther prevention of morbidities during the prenatal
period and increased quality of care provided by NICUs
to adequately manage such conditions, would therefore
significantly reduce the cost of prematurity. Our findings
highlight that the existing DRGs and relative tariffs in
use in Italy to fund NICUs inadequately reflect the
NICU’s actual costs.
In addition, our study suggests that when estimating
the cost of prematurity after the initial hospitalisation,
one should not only calculate healthcare costs but also
the burden on the families and caregivers of these in-
fants because these costs greatly exceed the healthcare
cost for VLBWIs after the initial discharge. The burden
of very low birth weight goes far beyond the cost that
the National Health Service covers because the birth of
a preterm infant may also have an economic impact over
time on other parties. Decision makers and healthcare
providers should be aware of the total cost supported by
society when considering different sources of expend-
iture to design policies targeted to a reduction and a fair
distribution of the total societal burden and not on the
healthcare burden alone.
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